Polymerase Mechanism-Based Method of Viral Attenuation

Area of Science:

• Virology
• Vaccinology
• Molecular Biology

Background:

• Live attenuated virus (LAV) vaccines are highly efficacious but pose safety risks due to potential reversion to virulence.
• Current LAV development is often empirical, lacking understanding of molecular attenuation mechanisms.
• RNA viruses' high error rates and host pressures necessitate rational design for stable LAVs.

Purpose of the Study:

• To develop a rational design strategy for creating safer and genetically stable live attenuated virus (LAV) vaccines.
• To identify conserved viral polymerase residues crucial for attenuation and genetic stability.
• To investigate a high-fidelity viral RNA-dependent RNA polymerase (RdRp) mutant for vaccine development.

Main Methods:

• Identified a conserved lysine residue in the active site of the poliovirus (PV) RNA-dependent RNA polymerase (RdRp).
• Mutated the lysine to arginine to create a high-fidelity polymerase, reducing viral mutation frequency.
• Evaluated viral fidelity and attenuation in cell culture (in vitro) and a poliovirus transgenic murine model (in vivo).

Main Results:

• Mutation of the conserved lysine to arginine resulted in a high-fidelity PV RdRp.
• The high-fidelity polymerase exhibited slow replication, leading to viral attenuation.
• The attenuated virus demonstrated genetic stability, reducing the likelihood of reversion to wild-type virulence.

Conclusions:

• Targeting conserved residues in viral polymerases offers a rational approach to LAV vaccine design.
• A high-fidelity RdRp mutant, like the K-to-R mutation, can yield genetically stable and attenuated viruses.
• This strategy holds promise for developing safer and more reliable LAV vaccines against RNA viruses.